Here, we aimed to assess the expression level of NLRP3 in ovarian cancer with DDP resistance, clarify its potential regulatory role, and offer new therapeutic strategies for the advancement of chemoresistance in ovarian cancer. This evidence concerns the gene NLRP3 and ovarian cancer.